Canada markets closed

AstraZeneca PLC (AZNCF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
136.70+2.92 (+2.18%)
At close: 03:21PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 202.93B
Enterprise Value 225.91B
Trailing P/E 61.87
Forward P/E 17.92
PEG Ratio (5 yr expected) 2.00
Price/Sales (ttm)4.59
Price/Book (mrq)5.46
Enterprise Value/Revenue 5.09
Enterprise Value/EBITDA 24.87

Trading Information

Stock Price History

Beta (5Y Monthly) 0.17
52-Week Change 32.45%
S&P500 52-Week Change 3-13.21%
52 Week High 3144.50
52 Week Low 3104.50
50-Day Moving Average 3133.20
200-Day Moving Average 3127.35

Share Statistics

Avg Vol (3 month) 31.98k
Avg Vol (10 day) 33.29k
Shares Outstanding 51.55B
Implied Shares Outstanding 6N/A
Float 81.54B
% Held by Insiders 10.22%
% Held by Institutions 147.74%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 42.83
Forward Annual Dividend Yield 42.12%
Trailing Annual Dividend Rate 32.90
Trailing Annual Dividend Yield 32.17%
5 Year Average Dividend Yield 42.84
Payout Ratio 4134.28%
Dividend Date 3Sept 08, 2019
Ex-Dividend Date 4Feb 22, 2023
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Dec 30, 2022


Profit Margin 7.41%
Operating Margin (ttm)20.21%

Management Effectiveness

Return on Assets (ttm)5.55%
Return on Equity (ttm)8.63%

Income Statement

Revenue (ttm)44.35B
Revenue Per Share (ttm)28.65
Quarterly Revenue Growth (yoy)-6.70%
Gross Profit (ttm)35.73B
Net Income Avi to Common (ttm)3.29B
Diluted EPS (ttm)2.16
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)6.24B
Total Cash Per Share (mrq)4.03
Total Debt (mrq)31.14B
Total Debt/Equity (mrq)84.02
Current Ratio (mrq)0.86
Book Value Per Share (mrq)23.90

Cash Flow Statement

Operating Cash Flow (ttm)9.81B
Levered Free Cash Flow (ttm)12.36B